Literature DB >> 7591089

Functional properties of isotype-switched immunoglobulin M (IgM) and IgG monoclonal antibodies to Pseudomonas aeruginosa lipopolysaccharide.

M Pollack1, N L Koles, M J Preston, B J Brown, G B Pier.   

Abstract

Controversy exists regarding isotype-related differences in the antibacterial and protective properties of lipopolysaccharide (LPS)-specific antibodies of the immunoglobulin M (IgM) class and various IgG subclasses. To clarify this issue, a murine hybridoma secreting IgM monoclonal antibody (MAb) specific for the O polysaccharide of Pseudomonas aeruginosa serogroup O6 LPS was class switched, by sib selection, to produce an IgG3 MAb with identical specificity and variable region heavy and light chain nucleotide sequences. This IgG3-secreting cell line was further switched to the production of O-specific, variable region-identical IgG1, IgG2b, and IgG2a MAbs. Functional comparisons of these LPS-specific IgM and IgG MAb isotypes revealed similar LPS binding, opsonic, and protective activities. Relatively minor isotype-related differences in levels of efficiency of MAb-mediated, complement-dependent opsonophagocytic killing (IgM > IgG2a > IgG3 > IgG2b > > IgG1) were not associated with corresponding differences in in vivo functions. These findings, in conjunction with previously published data, support a cautious approach to generic conclusions regarding the immunotherapeutic superiority of LPS-specific antibodies belonging to either the IgM or IgG class or to a particular IgG subclass.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7591089      PMCID: PMC173638          DOI: 10.1128/iai.63.11.4481-4488.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections.

Authors:  O R Pavlovskis; M Pollack; L T Callahan; B H Iglewski
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

2.  The identification of monoclonal class switch variants by sib selection and an ELISA assay.

Authors:  G Spira; A Bargellesi; J L Teillaud; M D Scharff
Journal:  J Immunol Methods       Date:  1984-11-30       Impact factor: 2.303

3.  Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors.

Authors:  L S Young; D Armstrong
Journal:  J Infect Dis       Date:  1972-09       Impact factor: 5.226

4.  Isolation and characterization of a high-molecular-weight polysaccharide from the slime of Pseudomonas aeruginosa.

Authors:  G B Pier; H F Sidberry; S Zolyomi; J C Sadoff
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

5.  Effects of IgM and IgG antibody in patients with bacteremia due to gram-negative bacilli.

Authors:  S H Zinner; W R McCabe
Journal:  J Infect Dis       Date:  1976-01       Impact factor: 5.226

6.  Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model.

Authors:  D D Stieritz; I A Holder
Journal:  J Infect Dis       Date:  1975-06       Impact factor: 5.226

7.  Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man.

Authors:  M Pollack; L S Young
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

8.  Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to Escherichia coli endotoxin core.

Authors:  M Pollack; A I Huang; R K Prescott; L S Young; K W Hunter; D F Cruess; C M Tsai
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

9.  Isotype of protective anti-Salmonella antibodies in experimental mouse salmonellosis.

Authors:  H Saxén; O Mäkelä; S B Svenson
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

10.  THE ISOLATION AND BIOLOGICAL ACTIVITIES OF RABBIT GAMMA M- AND GAMMA G-ANTI-SALMONELLA TYPHIMURIUM ANTIBODIES.

Authors:  J B ROBBINS; K KENNY; E SUTER
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

View more
  12 in total

1.  Problems in using statistical analysis of replacement and silent mutations in antibody genes for determining antigen-driven affinity selection.

Authors:  Biplab Bose; Subrata Sinha
Journal:  Immunology       Date:  2005-10       Impact factor: 7.397

2.  Older adults have a low capacity to opsonize pneumococci due to low IgM antibody response to pneumococcal vaccinations.

Authors:  Saeyoung Park; Moon H Nahm
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

3.  Immune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination.

Authors:  M A Julie Westerink; Harry W Schroeder; Moon H Nahm
Journal:  Aging Dis       Date:  2011-07-20       Impact factor: 6.745

4.  Phage display and bacterial expression of a recombinant Fab specific for Pseudomonas aeruginosa serotype O6 lipopolysaccharide.

Authors:  N L Tout; J S Lam
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

5.  Binding to and opsonophagocytic activity of O-antigen-specific monoclonal antibodies against encapsulated and nonencapsulated Klebsiella pneumoniae serotype O1 strains.

Authors:  T K Held; N R Jendrike; T Rukavina; R Podschun; M Trautmann
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

6.  Production and characterization of a set of mouse-human chimeric immunoglobulin G (IgG) subclass and IgA monoclonal antibodies with identical variable regions specific for Pseudomonas aeruginosa serogroup O6 lipopolysaccharide.

Authors:  M J Preston; A A Gerçeker; M E Reff; G B Pier
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Deficiency of mannose-binding lectin greatly increases antibody response in a mouse model of vaccination.

Authors:  Hilde-Kari Guttormsen; Lynda M Stuart; Lei Shi; Mike C Carroll; Jianzhu Chen; Dennis L Kasper; R Alan B Ezekowitz; Kazue Takahashi
Journal:  Clin Immunol       Date:  2008-11-08       Impact factor: 3.969

8.  Functional characterization and evaluation of in vitro protective efficacy of murine monoclonal antibodies BURK24 and BURK37 against Burkholderia pseudomallei.

Authors:  Bhavani V Peddayelachagiri; Soumya Paul; Shivakiran S Makam; Radhika M Urs; Joseph J Kingston; Urmil Tuteja; Murali H Sripathy; Harsh V Batra
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

9.  Impact of IgM Antibodies on Cross-Protection against Pneumococcal Serogroups 6 and 19 after Immunization with 7-Valent Pneumococcal Conjugate Vaccine in Children.

Authors:  Hye-Kyung Cho; In Ho Park; Robert L Burton; Kyung-Hyo Kim
Journal:  J Korean Med Sci       Date:  2016-04-19       Impact factor: 2.153

10.  Exchanging murine and human immunoglobulin constant chains affects the kinetics and thermodynamics of antigen binding and chimeric antibody autoreactivity.

Authors:  Marcela Torres; Narcis Fernandez-Fuentes; András Fiser; Arturo Casadevall
Journal:  PLoS One       Date:  2007-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.